Center for Molecular Medicine and Genetics (H.K., R.M., Z.Z., J.C., R.Z., K.Z.), Department of Immunology and Microbiology (K.Z.), The Wayne State University School of Medicine, Detroit, Michigan 48201; and Cardiovascular Center (L.C.), Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109.
Endocrinology. 2014 Mar;155(3):769-82. doi: 10.1210/en.2013-1490. Epub 2014 Jan 1.
Lipid metabolism is tightly regulated by nuclear receptors, transcription factors, and cellular enzymes. In this study, we demonstrated that the liver-enriched transcription factor CREBH (cAMP-responsive element binding protein, hepatocyte specific) and peroxisome proliferator-activated receptor α (PPARα) function as binary transcriptional activators to regulate lipid metabolism by activating fibroblast growth factor 21 (FGF21), a hepatic hormone that regulates whole-body energy homeostasis. Gain- and loss-of-function studies indicated that CREBH regulates triglyceride and fatty acid metabolism in animals under fasting or on an atherogenic high-fat (AHF) diet. CREBH and PPARα act as interactive trans-activators that regulate each other for their expression. Activated CREBH protein interacts with PPARα to form a functional complex upon fasting or the AHF diet, and both factors are required for induction of the metabolic hormone FGF21. The CREBH-PPARα complex was found to bind to integrated CRE-PPAR-responsive element-binding motifs in the FGF21 gene promoter. Whereas CREBH and PPARα function in synergy to activate FGF21 gene expression, PPARα relies on CREBH to exert its trans-activation effect on FGF21. Supporting the key role of CREBH in regulating FGF21, infusion of recombinant FGF21 protein can reverse hypertriglyceridemia and hypoketonemia and partially rescue nonalcoholic steatohepatitis developed in the CREBH-null mice after the AHF diet. Our study demonstrated a transcriptional regulatory axis of CREBH-PPARα-FGF21 in maintaining lipid homeostasis under metabolic stress. The functional relationship between CREBH and PPARα in regulating FGF21 may represent an important transcriptional coactivation mechanism that orchestrates the processes of energy supply upon metabolic alteration.
脂质代谢受到核受体、转录因子和细胞酶的严格调控。在这项研究中,我们证明了富含肝的转录因子 CREBH(cAMP 反应元件结合蛋白,肝细胞特异性)和过氧化物酶体增殖物激活受体α(PPARα)作为二元转录激活因子,通过激活成纤维细胞生长因子 21(FGF21)来调节脂质代谢,FGF21 是一种调节全身能量稳态的肝脏激素。获得和缺失功能的研究表明,CREBH 在动物禁食或动脉粥样硬化高脂肪(AHF)饮食下调节甘油三酯和脂肪酸代谢。CREBH 和 PPARα 作为交互转录激活因子,通过调节彼此的表达来发挥作用。在禁食或 AHF 饮食下,激活的 CREBH 蛋白与 PPARα 相互作用形成功能性复合物,并且这两种因子对于诱导代谢激素 FGF21 都是必需的。发现 CREBH-PPARα 复合物结合到 FGF21 基因启动子的整合 CRE-PPAR 反应元件结合基序上。虽然 CREBH 和 PPARα 协同作用激活 FGF21 基因表达,但 PPARα 依赖于 CREBH 发挥其对 FGF21 的转录激活作用。支持 CREBH 在调节 FGF21 中的关键作用,重组 FGF21 蛋白的输注可以逆转 CREBH 基因敲除小鼠在 AHF 饮食后发生的高甘油三酯血症和酮血症,并部分挽救非酒精性脂肪性肝炎的发展。我们的研究证明了 CREBH-PPARα-FGF21 在代谢应激下维持脂质稳态的转录调节轴。在调节 FGF21 方面,CREBH 和 PPARα 之间的功能关系可能代表一种重要的转录共激活机制,协调代谢改变时的能量供应过程。